Cargando…

Anticoagulant Related Nephropathy Induced by Dabigatran

We describe a case of biopsy-proven dabigatran related nephropathy in a patient without underlying IgA nephropathy. To date, dabigatran related nephropathy was only reported in patients with concurrent or undiagnosed IgA nephropathy, suggesting that it may predispose patients to dabigatran associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharfuddin, Nazia, Nourbakhsh, Mahra, Box, Alan, Benediktsson, Hallgrimur, Muruve, Daniel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304482/ https://www.ncbi.nlm.nih.gov/pubmed/30631615 http://dx.doi.org/10.1155/2018/7381505

Ejemplares similares

Sociodemographic associations with abnormal estimated glomerular filtration rate (eGFR) in a large Canadian city: a cross-sectional observation study
por: Ma, Irene, et al.
Publicado: (2018)

A case of aggressive atypical anti-GBM disease complicated by CMV pneumonitis
por: Sporinova, Barbora, et al.
Publicado: (2019)

Trends in Biopsy-Based Diagnosis of Kidney Disease: A Population Study
por: Cunningham, Amanda, et al.
Publicado: (2018)

Dabigatran-Related Nephropathy in a Patient with Undiagnosed IgA Nephropathy
por: Escoli, Rachele, et al.
Publicado: (2015)

Idarucizumab for the treatment of dabigatran-related nephropathy
por: Alsamarrai, Ammar, et al.
Publicado: (2020)

Promise and challenges of anticoagulation with dabigatran
por: Verma, Ashish, et al.
Publicado: (2012)

NLRP3 Localizes to the Tubular Epithelium in Human Kidney and Correlates With Outcome in IgA Nephropathy
por: Chun, Justin, et al.
Publicado: (2016)

A novel oral anticoagulant, dabigatran, in acute renal infarction
por: Altın, Cihan, et al.
Publicado: (2015)

Dabigatran-Induced Acute Interstitial Nephritis: An Important Complication of Newer Oral Anticoagulation Agents
por: Patel, Swapnil, et al.
Publicado: (2018)

The biobank for the molecular classification of kidney disease: research translation and precision medicine in nephrology
por: Muruve, Daniel A., et al.
Publicado: (2017)

Idarucizumab reverses dabigatran-induced anticoagulation in treatment of gastric bleeding: A case report
por: Jia, Yu, et al.
Publicado: (2022)

Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin
por: Moeckel, Gilbert W., et al.
Publicado: (2013)

Delayed concentration effect models for dabigatran anticoagulation
por: Eaton, Michael P., et al.
Publicado: (2022)

Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
por: Kim, Jong-Min, et al.
Publicado: (2022)

Use of Idarucizumab to Revert the Anticoagulant Effect of Dabigatran in Heart Transplant Surgery: An Institutional Experience
por: Herrera-Escandón, Álvaro, et al.
Publicado: (2020)

Bioptically Proven “Anticoagulation-Related Nephropathy“ Induced by Dual Antiplatelet Therapy
por: Krátká, Karolína, et al.
Publicado: (2018)

Case Report: Biliary Pancreatitis With Acute Cholangitis in a Patient Under Anticoagulant Treatment With Dabigatran
por: Baumann-Durchschein, Franziska, et al.
Publicado: (2017)

Features of Pharmacodynamics of the Anticoagulant Dabigatran in Secondary Thrombophilia
por: Kairov, Gaisa T., et al.
Publicado: (2018)

Dabigatran-Induced Massive Spontaneous Hemothorax
por: Huang, Jing, et al.
Publicado: (2017)

Hip arthroplasty fatality related to dabigatran induced gastrointestinal haemorrhage
por: Carter, A, et al.
Publicado: (2014)

New options with dabigatran etexilate in anticoagulant therapy
por: Maegdefessel, Lars, et al.
Publicado: (2010)

Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report
por: Agosti, Sergio, et al.
Publicado: (2017)

Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran
por: Glund, Stephan, et al.
Publicado: (2019)

Thrombocytopenia induced by dabigatran: two case reports
por: Kang, Hyun Goo, et al.
Publicado: (2017)

Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
por: Grottke, Oliver, et al.
Publicado: (2016)

Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran
por: Giannandrea, David, et al.
Publicado: (2019)

Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins
por: Jakimczuk, Aleksandra, et al.
Publicado: (2022)

Large Mobile Left Ventricular Thrombi Formation in a 32-Year-Old Despite Direct Oral Anticoagulation With Dabigatran
por: Weberling, Lukas Damian, et al.
Publicado: (2022)

Extensive spontaneous cervical epidural hematoma due to oral anticoagulant (dabigatran) successfully treated with reversal agent idarucizumab alone
por: Uddin, Syed-Abdullah, et al.
Publicado: (2022)

Dabigatran‐induced esophagitis with full circumferential blue pigmentation
por: Araki, Tomonori, et al.
Publicado: (2023)

Acute Kidney Injury due to Anticoagulant-Related Nephropathy : A Suggestion for Therapy
por: Zeni, Letizia, et al.
Publicado: (2020)

Dabigatran Associated Leukocytoclastic Vasculitis
por: Potolidis, Evangelos, et al.
Publicado: (2015)

Interstitial pneumonia caused by dabigatran
por: Yanagihara, Toyoshi, et al.
Publicado: (2017)

Idarucizumab to revert the anticoagulant effect of dabigatran in traumatic acute subdural haematoma: a case report of first use in Latin America
por: Izaguirre Ávila, Raúl, et al.
Publicado: (2019)

Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran
por: Sié, Pierre
Publicado: (2016)

Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis
por: Zhou, Ya, et al.
Publicado: (2021)

Effects of Simvastatin on Pharmacokinetics and Anticoagulant Effects of Dabigatran in Healthy Subjects
por: Chung, Hyewon, et al.
Publicado: (2023)

Simultaneous subacute interstitial nephritis and anticoagulant-related nephropathy related to novel oral anticoagulants use
por: Deng, Zhen-Ling, et al.
Publicado: (2022)

Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures
por: Andrade, Marcus Vinicius Santos, et al.
Publicado: (2018)

Dabigatran for intracardiac thrombus, yet another promising role of a direct oral anticoagulant: a case report and short review of literature
por: Kumar, Piyush, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2pkbfo7behu8nqpd08a9obgl78